Dr Amol Akhade· @SuyogCancer · X·· 20 小时前评分70
正文 · 机器翻译
Anbenitamab 联合 HB1801。来自中国的 Her2 靶向双特异性抗体和铝结合型 docetaxel，对比 THP。PFS HR 0.46。发表于 @nejm。Her2 阳性领域的探索进展迅速 @OncBrothers @OncoAlert @dr_yakupergun @myESMO #esmo26
331 浏览 · 6 赞 · 7 转发 · 0 回复
会议摘要
LBA15按 Proffered paper 2: Breast cancer, early and advanced stage 对上
Anbenitamab plus albumin-bound docetaxel in patients (pts) with HER2-positive advanced breast cancer (BC): A randomized phase III study
https://esmocongress.esmo.orgLBA80按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上
Anbenitamab plus chemotherapy for previously treated HER2-positive gastric or gastroesophageal carcinomas (GC/GEJC): Updated overall survival (OS) analysis of KC-WISE
https://esmocongress.esmo.org来源：Dr Amol Akhade · x.com